AKTS | AKTIS ONCOLOGY | Owners

S&P 500$7,757.17
+0.58%
2m
DOW 30$52,856.09
+0.69%
2m
NASDAQ 100$29,822.52
+1.13%
2m
Russell 2000$276.48
+0.25%
2m
Russell 1000$422.30
+0.59%
2m
S&P 400$3,665.94
+0.40%
2m
S&P 600$1,675.64
+0.08%
2m

AKTIS ONCOLOGY (AKTS)

NASDAQ

$16.75+$0.32 (+1.98%)

Price as of Oct 22, 2026 7:30 PM EDT

$882.5M
Market Cap
N/A
1-Year Change
Biotechnology
Industry

Top Holders

Institutional

Mutual Funds

Holder	Ownership %	Shares Held	Change (Shares, %)	Report Date
BIOIMPACT CAPITAL LLC	9.00%	4.8M	0 (0.00%)	Jun 30, 2026
ECOR1 CAPITAL, LLC	8.98%	4.8M	0 (0.00%)	Jun 30, 2026
VANGUARD GROUP INC	6.00%	3.2M	0 (0.00%)	Sep 30, 2024
BLUE OWL CAPITAL HOLDINGS LP	5.71%	3.1M	-91,129 (-2.97%)	Jun 30, 2026
TAYLOR FRIGON CAPITAL MANAGEMENT LLC	4.78%	2.6M	-225,494 (-8.78%)	Sep 30, 2024
SILVERBACK ASSET MANAGEMENT LLC	4.72%	2.5M	0 (0.00%)	Sep 30, 2024
ELEMENTAL CAPITAL PARTNERS LLC	4.65%	2.5M	-30,795 (-1.23%)	Sep 30, 2022

Holder	Ownership %	Shares Held	Change (Shares, %)	Report Date
VANGUARD SPECIALIZED FUNDS	2.72%	1.5M	-561,400 (-38.39%)	Jul 31, 2026
VANGUARD INDEX FUNDS	1.48%	794,951	-20,559 (-2.59%)	Jun 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.	1.26%	676,577	+64,030 (+9.46%)	Jun 30, 2026
MUTUAL FUND SERIES TRUST	0.94%	507,000	0 (0.00%)	Jun 30, 2026
T. Rowe Price Equity Funds, Inc.	0.67%	358,947	+38,197 (+10.64%)	Jun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.	0.62%	333,745	0 (0.00%)	Jun 30, 2026
FIDELITY SALEM STREET TRUST	0.43%	232,435	+209,507 (+90.14%)	Jul 31, 2026

Current Ownership Distribution

Institutions433.6M (75.41%)
Mutual Funds126.6M (22.02%)
Insiders14.7M (2.56%)
Other0 (0.00%)

Insider Transactions

2.56% (14.7M)
Current InsiderOwnership (%, shares)
3
Number of InsiderBuying (last 12 months)
$401.3M
Amount of InsiderBuying (last 12 months)
2
Number of InsiderSelling (last 12 months)
$1.7M
Amount of InsiderSelling (last 12 months)

Insider Name & Title	Type	Date	Transaction Value	Shares	Share Price	Shares After Transactions
Czibere Akos Chief Medical Officer	Exempt	Sep 23, 2026	$0.00	12,500	$0.00	208,718
Czibere Akos Chief Medical Officer	Exempt	Sep 23, 2026	$61,875.00	12,500	$4.95	12,500
Czibere Akos Chief Medical Officer	Sell	Sep 23, 2026	$102,972.78	5,099	$20.19	7,401
Czibere Akos Chief Medical Officer	Sell	Sep 23, 2026	$155,648.21	7,401	$21.03	0
Herrmann Ken	Exempt	Jul 20, 2026	$0.00	3,506	$0.00	0
Herrmann Ken	Exempt	Jul 20, 2026	$0.00	1,350	$0.00	18,364
Herrmann Ken	Exempt	Jul 20, 2026	$280.48	3,506	$0.08	3,506
Herrmann Ken	Exempt	Jul 20, 2026	$2,578.50	1,350	$1.91	4,856
Herrmann Ken	Sell	Jul 20, 2026	$86,115.07	3,506	$24.56	1,350
Herrmann Ken	Sell	Jul 20, 2026	$33,158.97	1,350	$24.56	0
Czibere Akos Chief Medical Officer	Exempt	Jul 08, 2026	$0.00	50,000	$0.00	221,218
Czibere Akos Chief Medical Officer	Exempt	Jul 08, 2026	$247,500.00	50,000	$4.95	50,000
Czibere Akos Chief Medical Officer	Sell	Jul 08, 2026	$401,484.04	14,800	$27.13	35,200
Czibere Akos Chief Medical Officer	Sell	Jul 08, 2026	$861,735.29	30,829	$27.95	4,371
Czibere Akos Chief Medical Officer	Sell	Jul 08, 2026	$125,481.79	4,371	$28.71	0
GADICKE ANSBERT	Conversion	Jan 12, 2026	$0.00	5.0M	$0.00	0
MPM BIOVENTURES 2018, L.P.	Conversion	Jan 12, 2026	$0.00	5.0M	$0.00	0
GADICKE ANSBERT	Conversion	Jan 12, 2026	$0.00	22.5M	$0.00	0
Foley Todd	Conversion	Jan 12, 2026	$0.00	2.3M	$0.00	0
GADICKE ANSBERT	Conversion	Jan 12, 2026	$0.00	6.0M	$0.00	0
MPM BIOVENTURES 2018, L.P.	Conversion	Jan 12, 2026	$0.00	22.5M	$0.00	0
GADICKE ANSBERT	Conversion	Jan 12, 2026	$0.00	1.3M	$0.00	1.7M
Foley Todd	Conversion	Jan 12, 2026	$0.00	10.2M	$0.00	0
GADICKE ANSBERT	Conversion	Jan 12, 2026	$0.00	5.9M	$0.00	7.6M
MPM BIOVENTURES 2018, L.P.	Conversion	Jan 12, 2026	$0.00	6.0M	$0.00	0
GADICKE ANSBERT	Conversion	Jan 12, 2026	$0.00	1.6M	$0.00	9.1M
Foley Todd	Conversion	Jan 12, 2026	$0.00	2.7M	$0.00	0
GADICKE ANSBERT	Buy	Jan 12, 2026	$20.0M	1.1M	$18.00	10.3M
MPM BIOVENTURES 2018, L.P.	Conversion	Jan 12, 2026	$0.00	1.3M	$0.00	1.7M
Foley Todd	Conversion	Jan 12, 2026	$0.00	597,391	$0.00	597,391